Global Golimumab (Simponi) Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

TABLE OF CONTENTS

1 Golimumab (Simponi) Market Overview

• 1.1 Golimumab (Simponi) Product Overview
• 1.2 Golimumab (Simponi) Market Segment by Type
  • 1.2.1 100Mg/Ml
  • 1.2.2 50Mg/Ml
  • 1.2.3 10Mg/Ml
• 1.3 Global Golimumab (Simponi) Market Size by Type
  • 1.3.1 Global Golimumab (Simponi) Market Size Overview by Type (2018-2029)
  • 1.3.2 Global Golimumab (Simponi) Historic Market Size Review by Type (2018-2023)
  • 1.3.3 Global Golimumab (Simponi) Forecasted Market Size by Type (2024-2029)
• 1.4 Key Regions Market Size Segment by Type
  • 1.4.1 North America Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
  • 1.4.2 Europe Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
  • 1.4.3 Asia-Pacific Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
  • 1.4.4 Latin America Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
  • 1.4.5 Middle East and Africa Golimumab (Simponi) Sales Breakdown by Type (2018-2023)

2 Global Golimumab (Simponi) Market Competition by Company

• 2.1 Global Top Players by Golimumab (Simponi) Sales (2018-2023)
• 2.2 Global Top Players by Golimumab (Simponi) Revenue (2018-2023)
• 2.3 Global Top Players by Golimumab (Simponi) Price (2018-2023)
• 2.4 Global Top Manufacturers Golimumab (Simponi) Manufacturing Base Distribution, Sales Area, Product Type
• 2.5 Golimumab (Simponi) Market Competitive Situation and Trends
  • 2.5.1 Golimumab (Simponi) Market Concentration Rate (2018-2023)
  • 2.5.2 Global 5 and 10 Largest Manufacturers by Golimumab (Simponi) Sales and Revenue in 2022
• 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Golimumab (Simponi) as of 2022)
• 2.7 Date of Key Manufacturers Enter into Golimumab (Simponi) Market
• 2.8 Key Manufacturers Golimumab (Simponi) Product Offered
• 2.9 Mergers & Acquisitions, Expansion

3 Golimumab (Simponi) Status and Outlook by Region

• 3.1 Global Golimumab (Simponi) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
• 3.2 Global Golimumab (Simponi) Historic Market Size by Region
  • 3.2.1 Global Golimumab (Simponi) Sales in Volume by Region (2018-2023)
  • 3.2.2 Global Golimumab (Simponi) Sales in Value by Region (2018-2023)
  • 3.2.3 Global Golimumab (Simponi) Sales (Volume & Value) Price and Gross Margin (2018-2023)
• 3.3 Global Golimumab (Simponi) Forecasted Market Size by Region
  • 3.3.1 Global Golimumab (Simponi) Sales in Volume by Region (2024-2029)
  • 3.3.2 Global Golimumab (Simponi) Sales in Value by Region (2024-2029)
  • 3.3.3 Global Golimumab (Simponi) Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Golimumab (Simponi) by Application

• 4.1 Golimumab (Simponi) Market Segment by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Other
• 4.2 Global Golimumab (Simponi) Market Size by Application
  • 4.2.1 Global Golimumab (Simponi) Market Size Overview by Application (2018-2029)
  • 4.2.2 Global Golimumab (Simponi) Historic Market Size Review by Application (2018-2023)
  • 4.2.3 Global Golimumab (Simponi) Forecasted Market Size by Application (2024-2029)
• 4.3 Key Regions Market Size Segment by Application
  • 4.3.1 North America Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
  • 4.3.2 Europe Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
  • 4.3.3 Asia-Pacific Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
  • 4.3.4 Latin America Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
  • 4.3.5 Middle East and Africa Golimumab (Simponi) Sales Breakdown by Application (2018-2023)

5 North America Golimumab (Simponi) by Country

• 5.1 North America Golimumab (Simponi) Historic Market Size by Country
  • 5.1.1 North America Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 5.1.2 North America Golimumab (Simponi) Sales in Volume by Country (2018-2023)
  • 5.1.3 North America Golimumab (Simponi) Sales in Value by Country (2018-2023)
• 5.2 North America Golimumab (Simponi) Forecasted Market Size by Country
  • 5.2.1 North America Golimumab (Simponi) Sales in Volume by Country (2024-2029)
  • 5.2.2 North America Golimumab (Simponi) Sales in Value by Country (2024-2029)

6 Europe Golimumab (Simponi) by Country

• 6.1 Europe Golimumab (Simponi) Historic Market Size by Country
  • 6.1.1 Europe Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 6.1.2 Europe Golimumab (Simponi) Sales in Volume by Country (2018-2023)
  • 6.1.3 Europe Golimumab (Simponi) Sales in Value by Country (2018-2023)
• 6.2 Europe Golimumab (Simponi) Forecasted Market Size by Country
  • 6.2.1 Europe Golimumab (Simponi) Sales in Volume by Country (2024-2029)
  • 6.2.2 Europe Golimumab (Simponi) Sales in Value by Country (2024-2029)

7 Asia-Pacific Golimumab (Simponi) by Region

• 7.1 Asia-Pacific Golimumab (Simponi) Historic Market Size by Region
  • 7.1.1 Asia-Pacific Golimumab (Simponi) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
  • 7.1.2 Asia-Pacific Golimumab (Simponi) Sales in Volume by Region (2018-2023)
  • 7.1.3 Asia-Pacific Golimumab (Simponi) Sales in Value by Region (2018-2023)
• 7.2 Asia-Pacific Golimumab (Simponi) Forecasted Market Size by Region
  • 7.2.1 Asia-Pacific Golimumab (Simponi) Sales in Volume by Region (2024-2029)
  • 7.2.2 Asia-Pacific Golimumab (Simponi) Sales in Value by Region (2024-2029)

8 Latin America Golimumab (Simponi) by Country

• 8.1 Latin America Golimumab (Simponi) Historic Market Size by Country
  • 8.1.1 Latin America Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 8.1.2 Latin America Golimumab (Simponi) Sales in Volume by Country (2018-2023)
  • 8.1.3 Latin America Golimumab (Simponi) Sales in Value by Country (2018-2023)
• 8.2 Latin America Golimumab (Simponi) Forecasted Market Size by Country
  • 8.2.1 Latin America Golimumab (Simponi) Sales in Volume by Country (2024-2029)
  • 8.2.2 Latin America Golimumab (Simponi) Sales in Value by Country (2024-2029)

9 Middle East and Africa Golimumab (Simponi) by Country

• 9.1 Middle East and Africa Golimumab (Simponi) Historic Market Size by Country
  • 9.1.1 Middle East and Africa Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 9.1.2 Middle East and Africa Golimumab (Simponi) Sales in Volume by Country (2018-2023)
  • 9.1.3 Middle East and Africa Golimumab (Simponi) Sales in Value by Country (2018-2023)
• 9.2 Middle East and Africa Golimumab (Simponi) Forecasted Market Size by Country
  • 9.2.1 Middle East and Africa Golimumab (Simponi) Sales in Volume by Country (2024-2029)
  • 9.2.2 Middle East and Africa Golimumab (Simponi) Sales in Value by Country (2024-2029)

10 Company Profiles

• 10.1 Chemieliva Pharma
  • 10.1.1 Chemieliva Pharma Company Information
  • 10.1.2 Chemieliva Pharma Introduction and Business Overview
  • 10.1.3 Chemieliva Pharma Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
  • 10.1.4 Chemieliva Pharma Golimumab (Simponi) Products Offered
  • 10.1.5 Chemieliva Pharma Recent Development
• 10.2 JNJ
  • 10.2.1 JNJ Company Information
  • 10.2.2 JNJ Introduction and Business Overview
  • 10.2.3 JNJ Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
  • 10.2.4 JNJ Golimumab (Simponi) Products Offered
  • 10.2.5 JNJ Recent Development
• 10.3 DSK Biopharma
  • 10.3.1 DSK Biopharma Company Information
  • 10.3.2 DSK Biopharma Introduction and Business Overview
  • 10.3.3 DSK Biopharma Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
  • 10.3.4 DSK Biopharma Golimumab (Simponi) Products Offered
  • 10.3.5 DSK Biopharma Recent Development
• 10.4 MSD
  • 10.4.1 MSD Company Information
  • 10.4.2 MSD Introduction and Business Overview
  • 10.4.3 MSD Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
  • 10.4.4 MSD Golimumab (Simponi) Products Offered
  • 10.4.5 MSD Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

• 11.1 Golimumab (Simponi) Key Raw Materials
  • 11.1.1 Key Raw Materials
  • 11.1.2 Key Raw Materials Price
  • 11.1.3 Raw Materials Key Suppliers
• 11.2 Manufacturing Cost Structure
  • 11.2.1 Raw Materials
  • 11.2.2 Labor Cost
  • 11.2.3 Manufacturing Expenses
• 11.3 Golimumab (Simponi) Industrial Chain Analysis
• 11.4 Golimumab (Simponi) Market Dynamics
  • 11.4.1 Golimumab (Simponi) Industry Trends
  • 11.4.2 Golimumab (Simponi) Market Drivers
  • 11.4.3 Golimumab (Simponi) Market Challenges
  • 11.4.4 Golimumab (Simponi) Market Restraints

12 Market Strategy Analysis, Distributors

• 12.1 Sales Channel
• 12.2 Golimumab (Simponi) Distributors
• 12.3 Golimumab (Simponi) Downstream Customers

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

• Table 1. Major Company of 100Mg/Ml
• Table 2. Major Company of 50Mg/Ml
• Table 3. Major Company of 10Mg/Ml
• Table 4. Global Golimumab (Simponi) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Golimumab (Simponi) Sales by Type (2018-2023) & (Box)
• Table 6. Global Golimumab (Simponi) Sales Market Share in Volume by Type (2018-2023)
• Table 7. Global Golimumab (Simponi) Sales by Type (2018-2023) & (US& Million)
• Table 8. Global Golimumab (Simponi) Market Share in Value by Type (2018-2023)
• Table 9. Global Golimumab (Simponi) Price by Type (2018-2023) & (US$/Box)
• Table 10. Global Golimumab (Simponi) Sales by Type (2024-2029) & (Box)
• Table 11. Global Golimumab (Simponi) Sales Market Share in Volume by Type (2024-2029)
• Table 12. Global Golimumab (Simponi) Sales by Type (2024-2029) & (US$ Million)
• Table 13. Global Golimumab (Simponi) Sales Market Share in Value by Type (2024-2029)
• Table 14. Global Golimumab (Simponi) Price by Type (2024-2029) & (US$/Box)
• Table 15. North America Golimumab (Simponi) Sales by Type (2018-2023) & (Box)
• Table 16. North America Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
• Table 17. Europe Golimumab (Simponi) Sales (Box) by Type (2018-2023)
• Table 18. Europe Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
• Table 19. Asia-Pacific Golimumab (Simponi) Sales (Box) by Type (2018-2023)
• Table 20. Asia-Pacific Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
• Table 21. Latin America Golimumab (Simponi) Sales (Box) by Type (2018-2023)
• Table 22. Latin America Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
• Table 23. Middle East and Africa Golimumab (Simponi) Sales (Box) by Type (2018-2023)
• Table 24. Middle East and Africa Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
• Table 25. Global Golimumab (Simponi) Sales by Company (2018-2023) & (Box)
• Table 26. Global Golimumab (Simponi) Sales Share by Company (2018-2023)
• Table 27. Global Golimumab (Simponi) Revenue by Company (2018-2023) & (US$ Million)
• Table 28. Global Golimumab (Simponi) Revenue Share by Company (2018-2023)
• Table 29. Global Market Golimumab (Simponi) Price by Company (2018-2023) & (US$/Box)
• Table 30. Global Golimumab (Simponi) Top Manufacturers Manufacturing Base Distribution and Sales Area
• Table 31. Global Golimumab (Simponi) Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Golimumab (Simponi) as of 2022)
• Table 33. Date of Key Manufacturers Enter into Golimumab (Simponi) Market
• Table 34. Key Manufacturers Golimumab (Simponi) Product Type
• Table 35. Mergers & Acquisitions, Expansion Plans
• Table 36. Global Golimumab (Simponi) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 37. Global Golimumab (Simponi) Sales by Region (2018-2023) & (Box)
• Table 38. Global Golimumab (Simponi) Sales Market Share in Volume by Region (2018-2023)
• Table 39. Global Golimumab (Simponi) Sales by Region (2018-2023) & (US$ Million)
• Table 40. Global Golimumab (Simponi) Sales Market Share in Value by Region (2018-2023)
• Table 41. Global Golimumab (Simponi) Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
• Table 42. Global Golimumab (Simponi) Sales by Region (2024-2029) & (Box)
• Table 43. Global Golimumab (Simponi) Sales Market Share in Volume by Region (2024-2029)
• Table 44. Global Golimumab (Simponi) Sales by Region (2024-2029) & (US$ Million)
• Table 45. Global Golimumab (Simponi) Sales Market Share in Value by Region (2024-2029)
• Table 46. Global Golimumab (Simponi) Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2024-2029)
• Table 47. Global Golimumab (Simponi) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
• Table 48. Global Golimumab (Simponi) Sales by Application (2018-2023) & (Box)
• Table 49. Global Golimumab (Simponi) Sales Market Share in Volume by Application (2018-2023)
• Table 50. Global Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 51. Global Golimumab (Simponi) Sales Market Share in Value by Application (2018-2023)
• Table 52. Global Golimumab (Simponi) Price by Application (2018-2023) & (US$/Box)
• Table 53. Global Golimumab (Simponi) Sales by Application (2024-2029) & (Box)
• Table 54. Global Golimumab (Simponi) Sales Market Share in Volume by Application (2024-2029)
• Table 55. Global Golimumab (Simponi) Sales by Application (2024-2029) & (US$ Million)
• Table 56. Global Golimumab (Simponi) Sales Market Share in Value by Application (2024-2029)
• Table 57. Global Golimumab (Simponi) Price by Application (2024-2029) & (US$/Box)
• Table 58. North America Golimumab (Simponi) Sales by Application (2018-2023) (Box)
• Table 59. North America Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 60. Europe Golimumab (Simponi) Sales by Application (2018-2023) (Box)
• Table 61. Europe Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 62. Asia-Pacific Golimumab (Simponi) Sales by Application (2018-2023) (Box)
• Table 63. Asia-Pacific Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 64. Latin America Golimumab (Simponi) Sales by Application (2018-2023) (Box)
• Table 65. Latin America Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 66. Middle East and Africa Golimumab (Simponi) Sales by Application (2018-2023) (Box)
• Table 67. Middle East and Africa Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
• Table 68. North America Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
• Table 69. North America Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
• Table 70. North America Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
• Table 71. North America Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
• Table 72. North America Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
• Table 73. North America Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
• Table 74. North America Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
• Table 75. North America Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
• Table 76. Europe Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
• Table 77. Europe Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
• Table 78. Europe Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
• Table 79. Europe Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
• Table 80. Europe Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
• Table 81. Europe Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
• Table 82. Europe Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
• Table 83. Europe Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
• Table 84. Asia-Pacific Golimumab (Simponi) Sales by Region (2018-2023) & (Box)
• Table 85. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Region (2018-2023)
• Table 86. Asia-Pacific Golimumab (Simponi) Sales by Region (2018-2023) & (US$ Million)
• Table 87. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Region (2018-2023)
• Table 88. Asia-Pacific Golimumab (Simponi) Sales by Region (2024-2029) & (Box)
• Table 89. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Region (2024-2029)
• Table 90. Asia-Pacific Golimumab (Simponi) Sales by Region (2024-2029) & (US$ Million)
• Table 91. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Region (2024-2029)
• Table 92. Latin America Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
• Table 93. Latin America Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
• Table 94. Latin America Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
• Table 95. Latin America Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
• Table 96. Latin America Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
• Table 97. Latin America Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
• Table 98. Latin America Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
• Table 99. Latin America Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
• Table 100. Middle East and Africa Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
• Table 101. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
• Table 102. Middle East and Africa Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
• Table 103. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
• Table 104. Middle East and Africa Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
• Table 105. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
• Table 106. Middle East and Africa Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
• Table 107. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
• Table 108. Chemieliva Pharma Company Information
• Table 109. Chemieliva Pharma Introduction and Business Overview
• Table 110. Chemieliva Pharma Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
• Table 111. Chemieliva Pharma Golimumab (Simponi) Product
• Table 112. Chemieliva Pharma Recent Development
• Table 113. JNJ Company Information
• Table 114. JNJ Introduction and Business Overview
• Table 115. JNJ Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
• Table 116. JNJ Golimumab (Simponi) Product
• Table 117. JNJ Recent Development
• Table 118. DSK Biopharma Company Information
• Table 119. DSK Biopharma Introduction and Business Overview
• Table 120. DSK Biopharma Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
• Table 121. DSK Biopharma Golimumab (Simponi) Product
• Table 122. DSK Biopharma Recent Development
• Table 123. MSD Company Information
• Table 124. MSD Introduction and Business Overview
• Table 125. MSD Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
• Table 126. MSD Golimumab (Simponi) Product
• Table 127. MSD Recent Development
• Table 128. Key Raw Materials Lists
• Table 129. Raw Materials Key Suppliers Lists
• Table 130. Golimumab (Simponi) Market Trends
• Table 131. Golimumab (Simponi) Market Drivers
• Table 132. Golimumab (Simponi) Market Challenges
• Table 133. Golimumab (Simponi) Market Restraints
• Table 134. Golimumab (Simponi) Distributors List
• Table 135. Golimumab (Simponi) Downstream Customers
• Table 136. Research Programs/Design for This Report
• Table 137. Key Data Information from Secondary Sources
• Table 138. Key Data Information from Primary Sources

List of Figures

• Figure 1. Golimumab (Simponi) Product Picture
• Figure 2. Global Golimumab (Simponi) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Golimumab (Simponi) Market Size Status and Outlook (2018-2029) & (US$ Million)
• Figure 4. Global Golimumab (Simponi) Sales Status and Outlook (2018-2029) & (Box)
• Figure 5. Product Picture of 100Mg/Ml
• Figure 6. Global 100Mg/Ml Sales YoY Growth (2018-2029) & (Box)
• Figure 7. Product Picture of 50Mg/Ml
• Figure 8. Global 50Mg/Ml Sales YoY Growth (2018-2029) & (Box)
• Figure 9. Product Picture of 10Mg/Ml
• Figure 10. Global 10Mg/Ml Sales YoY Growth (2018-2029) & (Box)
• Figure 11. Global Golimumab (Simponi) Sales by Type (2018-2029) & (US$ Million)
• Figure 12. Global Golimumab (Simponi) Sales Market Share by Type in 2022 & 2029
• Figure 13. North America Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
• Figure 14. North America Golimumab (Simponi) Sales Market Share in Value by Type in 2022
• Figure 15. Europe Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
• Figure 16. Europe Golimumab (Simponi) Sales Market Share in Value by Type in 2022
• Figure 17. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
• Figure 18. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Type in 2022
• Figure 19. Latin America Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
• Figure 20. Latin America Golimumab (Simponi) Sales Market Share in Value by Type in 2022
• Figure 21. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
• Figure 22. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Type in 2022
• Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Golimumab (Simponi) Sales in 2022
• Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Golimumab (Simponi) Revenue in 2022
• Figure 25. Golimumab (Simponi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 26. Product Picture of Hospital
• Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (Box)
• Figure 28. Product Picture of Clinic
• Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (Box)
• Figure 30. Product Picture of Other
• Figure 31. Global Other Sales YoY Growth (2018-2029) & (Box)
• Figure 32. Global Golimumab (Simponi) Sales by Application (2018-2029) & (US$ Million)
• Figure 33. Global Golimumab (Simponi) Sales Market Share by Application in 2022 & 2029
• Figure 34. North America Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
• Figure 35. North America Golimumab (Simponi) Sales Market Share in Value by Application in 2022
• Figure 36. Europe Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
• Figure 37. Europe Golimumab (Simponi) Sales Market Share in Value by Application in 2022
• Figure 38. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
• Figure 39. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Application in 2022
• Figure 40. Latin America Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
• Figure 41. Latin America Golimumab (Simponi) Sales Market Share in Value by Application in 2022
• Figure 42. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Application in 2022
• Figure 43. Key Raw Materials Price
• Figure 44. Golimumab (Simponi) Manufacturing Cost Structure
• Figure 45. Golimumab (Simponi) Industrial Chain Analysis
• Figure 46. Channels of Distribution
• Figure 47. Distributors Profiles
• Figure 48. Bottom-up and Top-down Approaches for This Report
• Figure 49. Data Triangulation
• Figure 50. Key Executives Interviewed